JPS6425718A - Oral solid drug for treating syndrome of epilepsy or spasm - Google Patents

Oral solid drug for treating syndrome of epilepsy or spasm

Info

Publication number
JPS6425718A
JPS6425718A JP15246688A JP15246688A JPS6425718A JP S6425718 A JPS6425718 A JP S6425718A JP 15246688 A JP15246688 A JP 15246688A JP 15246688 A JP15246688 A JP 15246688A JP S6425718 A JPS6425718 A JP S6425718A
Authority
JP
Japan
Prior art keywords
pharmaceutical preparations
pharmaceutical
treating
syndrome
spasmodic
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP15246688A
Other languages
Japanese (ja)
Other versions
JPH0160452B2 (en
Inventor
Emu Meado Edouin
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Abbott Laboratories
Original Assignee
Abbott Laboratories
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Abbott Laboratories filed Critical Abbott Laboratories
Priority to JP15246688A priority Critical patent/JPS6425718A/en
Publication of JPS6425718A publication Critical patent/JPS6425718A/en
Publication of JPH0160452B2 publication Critical patent/JPH0160452B2/ja
Granted legal-status Critical Current

Links

Landscapes

  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

PURPOSE: To prepare a orally administered solid pharmaceutical for treating an epileptic seizure or spasmodic syndrome that enables easy production of solid pharmaceutical preparations having reduced hygroscopicity and improved stability while retaining an efficacy equivalent to or more than that of conventional pharmaceutical preparations by using crystalline single compound consisting of valpronic acid and sodium valproate at a specific mol ratio as the main active component. CONSTITUTION: This orally administered solid pharmaceutical effective for treating an epileptic seizure or spasmodic syndrome comprises a crystalline single compound consisting of valpronic acid and sodium valproate at a mol ratio of (1:1), and one or more excipients or diluents which are permitted for pharmaceutical preparations, thereby enabling production of pharmaceutical preparations in the solid form without special precautions and use of absorbents because its non-hygroscopicity and very high stability while exhibiting its efficacy of the same degree as that of the liquid valpronic acid and its sodium salt, which is hygroscopic and unstable. A specific amount of this pharmaceutical is mixed with starch and/or other binders to make a flowable powdery mixture, and the powdery mixture is granulated and then pelletized through a pelletizer, to provide the excellent pellets.
JP15246688A 1988-06-22 1988-06-22 Oral solid drug for treating syndrome of epilepsy or spasm Granted JPS6425718A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP15246688A JPS6425718A (en) 1988-06-22 1988-06-22 Oral solid drug for treating syndrome of epilepsy or spasm

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP15246688A JPS6425718A (en) 1988-06-22 1988-06-22 Oral solid drug for treating syndrome of epilepsy or spasm

Publications (2)

Publication Number Publication Date
JPS6425718A true JPS6425718A (en) 1989-01-27
JPH0160452B2 JPH0160452B2 (en) 1989-12-22

Family

ID=15541128

Family Applications (1)

Application Number Title Priority Date Filing Date
JP15246688A Granted JPS6425718A (en) 1988-06-22 1988-06-22 Oral solid drug for treating syndrome of epilepsy or spasm

Country Status (1)

Country Link
JP (1) JPS6425718A (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1479291A1 (en) 2003-05-19 2004-11-24 Shotaro Mochizuki Discharged waste processing materials for animals

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1479291A1 (en) 2003-05-19 2004-11-24 Shotaro Mochizuki Discharged waste processing materials for animals

Also Published As

Publication number Publication date
JPH0160452B2 (en) 1989-12-22

Similar Documents

Publication Publication Date Title
AU587863B2 (en) Vitamin-containing granules and production thereof
GB1226394A (en)
US2950309A (en) Amphetamine tannate
KR20040012569A (en) Pharmaceutical compositions with antibiotic activity
JPS6425718A (en) Oral solid drug for treating syndrome of epilepsy or spasm
JPS5610110A (en) Acetyl salicylate salt preparation for injection
JPS552601A (en) Anti-tumor agent for non-injection use
JPS5599164A (en) Feed for germfree animal, and its preparation
JPS5347515A (en) Gamma-globulin pharmaceutical preparation for intravenous injection
JPS5334716A (en) Preparation of amide amine amphoteric surface active agent
GB1359560A (en) Preparation of pyrrylsalicylic acid
IE44704L (en) ß-LACTAM ANTIBIOTIC
GB1187946A (en) Dimethylbiguanide Derivative
EP0127274A3 (en) Esters of metronidazole and compositions containing them
JPS5668672A (en) Novel 2-acetoxybenzamide derviative, its preparation, and pharmaceutical containing said derviative as effective component
JPS57106644A (en) Farnesence derivative, mucosa stabilizer comprising it as active ingredient, and its preparation
GB1470747A (en) Pyridazine derivative
ES8502436A1 (en) A compound with analgesic and anti-inflammatory activity, a process for producing same and related pharmaceutical compositions
DE3472554D1 (en) Cysteine derivatives, a process for their preparation, and pharmaceutical compostions which contain them
GB1125793A (en) Complexes of bismuth and chlorohydroxyquinoline and compositions containing them
JPS51115402A (en) Process for preparation of alpha-amino acid
ES8505644A1 (en) S-Carboxymethylcysteine derivatives having a therapeutic activity, process for their preparation and pharmaceutical compositions which contain them
ES8107049A1 (en) Acid-type ion exchange resins, their preparation, their use as medicines and compositions containing them.
JPS55108257A (en) Method for preventing laying of abnormal egg of quail, and powdery feed for quail
JPS57114510A (en) Hemostatic and platelet-increasing agent comprising d-beta- n-oxalo-alpha,beta-diaminopropionic acid